SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

Company Participation - SI-BONE, Inc. will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on September 9, 2025 [1] - Management will host a fireside chat at 4:00 a.m. Pacific Time / 07:00 a.m. Eastern Time [1] Investor Information - Investors can register for the conference call via a provided link and access the live audio webcast on the company's website [2] - The webcast will be archived for at least 90 days post-event [2] Company Overview - SI-BONE is a leader in developing technologies for surgical treatment of sacropelvic disorders, having pioneered minimally invasive SI joint surgery in 2009 with the iFuse Implant System [3] - The company has supported over 4,600 physicians in nearly 130,000 procedures, backed by over 175 peer-reviewed publications including four randomized controlled trials [3] - SI-BONE has expanded its offerings to adjacent markets such as adult deformity, spinopelvic and sacropelvic fixation, and pelvic trauma [3]